81 related articles for article (PubMed ID: 9298470)
1. Characteristics of volunteer participants in phase I HIV vaccine trials.
Crumbo CL; Rybczyk GK; Wagner LJ
J Assoc Nurses AIDS Care; 1997; 8(5):59-65. PubMed ID: 9298470
[TBL] [Abstract][Full Text] [Related]
2. Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
Nyaoke BA; Mutua GN; Sajabi R; Nyasani D; Mureithi MW; Anzala OA
PLoS One; 2017; 12(9):e0183788. PubMed ID: 28880880
[TBL] [Abstract][Full Text] [Related]
3. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
[TBL] [Abstract][Full Text] [Related]
4. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.
Van de Ven P; Mao L; Crawford J; Prestage G; Grulich A; Kaldor J; Kippax S
Int J STD AIDS; 2005 Apr; 16(4):314-7. PubMed ID: 15899086
[TBL] [Abstract][Full Text] [Related]
5. Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.
Jenkins RA; Chinaworapong S; Morgan PA; Ruangyuttikarn C; Sontirat A; Chiu J; Michael RA; Nitayaphan S; Khamboonruang C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):171-7. PubMed ID: 9637582
[TBL] [Abstract][Full Text] [Related]
6. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
[TBL] [Abstract][Full Text] [Related]
7. Perceptions of a community sample about participation in future HIV vaccine trials in south India.
Nyamathi AM; Suhadev M; Swaminathan S; Fahey JL
AIDS Behav; 2007 Jul; 11(4):619-27. PubMed ID: 17016758
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of attitude, risk behavior and expectations among Thai participants in Phase I/II HIV/AIDS vaccine trials.
Maek-A-Nantawat W; Pitisuttithum P; Phonrat B; Bussaratid V; Naksrisook S; Peonim W; Thantamnu N; Muanaum R
J Med Assoc Thai; 2003 Apr; 86(4):299-307. PubMed ID: 12757073
[TBL] [Abstract][Full Text] [Related]
9. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.
Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS
Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987
[TBL] [Abstract][Full Text] [Related]
10. Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
Nyasani DK; Mutua GN; Sajabi RM; Ng'ang'a JW; Gachie JN; Maina AM; Lusike LL; Anzala AO; Price MA; Manyonyi GO
PLoS One; 2018; 13(11):e0206656. PubMed ID: 30388145
[TBL] [Abstract][Full Text] [Related]
11. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India.
Newman PA; Chakrapani V; Weaver J; Shunmugam M; Rubincam C
Vaccine; 2014 Oct; 32(44):5854-61. PubMed ID: 25173475
[TBL] [Abstract][Full Text] [Related]
12. Correlates of HIV vaccine trial participation: an Indian perspective.
Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
[TBL] [Abstract][Full Text] [Related]
13. A pilot study on willingness to participate in future preventive HIV vaccine trials.
Suhadev M; Nyamathi AM; Swaminathan S; Venkatesan P; Raja Sakthivel M; Shenbagavalli R; Suresh A; Fahey JL
Indian J Med Res; 2006 Dec; 124(6):631-40. PubMed ID: 17287550
[TBL] [Abstract][Full Text] [Related]
14. Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials.
Hays RB; Kegeles SM
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):164-71. PubMed ID: 10048904
[TBL] [Abstract][Full Text] [Related]
15. Reasons for not participating in a phase 1 preventive HIV vaccine study in a resource-rich country.
Lucero MC; Diaz-Brito V; Murillo BT; Carretero SC; Sala M; Casadesús C; Conde MS; Jimenez JL; Pich J; Arnaiz JA; Leon A; Perez I; Muñoz-Fernández MÁ; Gatell JM; Plana M; Esteban M; Bernaldo de Quiros JC; Garcia F;
AIDS Patient Care STDS; 2012 Jul; 26(7):379-82. PubMed ID: 22694172
[No Abstract] [Full Text] [Related]
16. Physicians' group seeks volunteers for AIDS vaccine trial.
AIDS Policy Law; 1997 Sep; 12(16):5. PubMed ID: 11364670
[TBL] [Abstract][Full Text] [Related]
17. Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania.
Tarimo EA; Bakari M; Kakoko DC; Kohi TW; Mhalu F; Sandstrom E; Kulane A
BMC Public Health; 2016 Feb; 16():182. PubMed ID: 26911203
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya.
Jackson DJ; Martin HL; Bwayo JJ; Nyange PM; Rakwar JP; Kashonga F; Mandaliya K; Ndinya-Achola JO; Kreiss JK
AIDS; 1995 Nov; 9(11):1279-83. PubMed ID: 8561982
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials.
Gilbert PB; Chiu YL; Allen M; Lawrence DN; Chapdu C; Israel H; Holman D; Keefer MC; Wolff M; Frey SE;
Vaccine; 2003 Jun; 21(21-22):2933-47. PubMed ID: 12798637
[TBL] [Abstract][Full Text] [Related]
20. Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey.
Starace F; Wagner TM; Luzi AM; Cafaro L; Gallo P; Rezza G
AIDS Care; 2006 Jan; 18(1):66-72. PubMed ID: 16282079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]